Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2016, Article ID 1623094, 8 pages
http://dx.doi.org/10.1155/2016/1623094
Research Article

Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana

1Department of Molecular Medicine, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
2Medical Laboratory Department, Tamale Teaching Hospital, Tamale, Ghana
3Department of Medical Laboratory Sciences, University of Health and Allied Sciences, Ho, Ghana

Received 19 November 2015; Revised 29 January 2016; Accepted 1 March 2016

Academic Editor: Robert R. Redfield

Copyright © 2016 Christian Obirikorang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Tolentino and J. F. Friedman, “An update on anemia in less developed countries,” The American Journal of Tropical Medicine and Hygiene, vol. 77, no. 1, pp. 44–51, 2007. View at Google Scholar · View at Scopus
  2. R. Yip and U. Ramakrishnan, “Experiences and challenges in developing countries,” Journal of Nutrition, vol. 132, supplement 4, pp. 827S–830S, 2002. View at Google Scholar · View at Scopus
  3. WHO, Worldwide Prevalence of Anaemia 1993–2005, World Health Organization, Geneva, Switzerland, 2008.
  4. C. E. Bekolo, M. B. Nguena, L. Ewane, P. S. Bekoule, and B. Kollo, “The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population,” BMC Public Health, vol. 14, no. 1, article 236, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. UNAIDS, Global Report: UNAIDS Report on the Global AIDS Epidemic 2013, 2013.
  6. P. S. Belperio and D. C. Rhew, “Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature,” American Journal of Medicine, vol. 116, supplement 7, pp. 27–43, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Harris, J. A. C. Sterne, S. Abgrall et al., “Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies,” Antiviral Therapy, vol. 13, no. 8, pp. 959–967, 2008. View at Google Scholar · View at Scopus
  8. M. May, A. Boulle, S. Phiri et al., “Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes,” The Lancet, vol. 376, no. 9739, pp. 449–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. A. Stringer, I. Zulu, J. Levy et al., “Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes,” The Journal of the American Medical Association, vol. 296, no. 7, pp. 782–793, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-F. Etard, I. Ndiaye, M. Thierry-Mieg et al., “Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study,” AIDS, vol. 20, no. 8, pp. 1181–1189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Johannessen, E. Naman, B. J. Ngowi et al., “Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania,” BMC Infectious Diseases, vol. 8, article 52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. O'Brien, R. Kupka, G. I. Msamanga, E. Saathoff, D. J. Hunter, and W. W. Fawzi, “Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania,” Journal of Acquired Immune Deficiency Syndromes, vol. 40, no. 2, pp. 219–225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Obirikorang and F. A. Yeboah, “Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting,” Journal of Biomedical Science, vol. 16, no. 1, article 102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. G. Shaw and J. F. Friedman, “Iron deficiency anemia: focus on infectious diseases in lesser developed countries,” Anemia, vol. 2011, Article ID 260380, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. McDermid, A. Jaye, M. F. Schim Van Der Loeff et al., “Elevated iron status strongly predicts mortality in West African adults with HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 46, no. 4, pp. 498–507, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. W. Mburu, D. I. Thurnham, D. L. Mwaniki, E. M. Muniu, F. Alumasa, and A. De Wagt, “The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV+ Kenyan adults,” Journal of Nutrition, vol. 138, no. 3, pp. 613–619, 2008. View at Google Scholar · View at Scopus
  17. M. A. Salomé and H. Z. W. Grotto, “Human immunodeficiency virus-related anemia of chronic disease: relationship to hematologic, immune, and iron metabolism parameters, and lack of association with serum interferon-γ levels,” AIDS Patient Care and STDs, vol. 16, no. 8, pp. 361–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Boom, E. Kösters, C. Duncombe et al., “Ferritin levels during structured treatment interruption of highly active antiretroviral therapy,” HIV Medicine, vol. 8, no. 6, pp. 388–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Costantini, S. Giuliodoro, L. Butini, G. Silvestri, P. Leoni, and M. Montroni, “Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 1, pp. 70–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. Volberding, A. M. Levine, D. Dieterich, D. Mildvan, R. Mitsuyasu, and M. Saag, “Anemia in HIV infection: clinical impact and evidence-based management strategies,” Clinical Infectious Diseases, vol. 38, no. 10, pp. 1454–1463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Mocroft, O. Kirk, S. E. Barton et al., “Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe,” AIDS, vol. 13, no. 8, pp. 943–950, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. R. D. Moore and D. Forney, “Anemia in HIV-infected patients receiving highly active antiretroviral therapy,” Journal of Acquired Immune Deficiency Syndromes, vol. 29, no. 1, pp. 54–57, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Berhane, R. Karim, M. H. Cohen et al., “Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study,” Journal of Acquired Immune Deficiency Syndromes, vol. 37, no. 2, pp. 1245–1252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Obirikorang, P. K. Selleh, J. K. Abledu, and C. O. Fofie, “Predictors of adherence to antiretroviral therapy among HIV/AIDS patients in the upper west region of Ghana,” ISRN AIDS, vol. 2013, Article ID 873939, 7 pages, 2013. View at Publisher · View at Google Scholar
  25. T. Leenstra, S. K. Kariuki, J. D. Kurtis, A. J. Oloo, P. A. Kager, and F. O. ter Kuile, “Prevalence and severity of anemia and iron deficiency: cross-sectional studies in adolescent schoolgirls in western Kenya,” European Journal of Clinical Nutrition, vol. 58, no. 4, pp. 681–691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Konijn, “Iron metabolism in inflammation,” Baillière's Clinical Haematology, vol. 7, no. 4, pp. 829–849, 1994. View at Publisher · View at Google Scholar
  27. CDC, “1992 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults,” Morbidity and Mortality Weekly Report, vol. 41, no. 17, pp. 961–962, 1993. View at Google Scholar
  28. CDC, “Revised guidelines for performing CD4+ T-cell deter-minations in persons infected with human immunodeficiency virus (HIV),” Morbidity and Mortality Weekly Report, vol. 46, no. 2, pp. 1–29, 1997. View at Google Scholar
  29. F. F. Mandy, J. K. A. Nicholson, and J. S. McDougal, “Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus,” Morbidity and Mortality Weekly Report, vol. 52, no. 2, pp. 1–13, 2003. View at Google Scholar
  30. G. Moyle, “Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity,” AIDS Reviews, vol. 4, no. 1, pp. 13–20, 2002. View at Google Scholar · View at Scopus
  31. R. Wisaksana, R. Sumantri, A. R. Indrati et al., “Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia,” BMC Infectious Diseases, vol. 11, article 213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. WHO, Iron Deficiency Anaemia: Assessment, Prevention and Control, 2001, http://apps.who.int/iris/bitstream/10665/66914/1/WHO_NHD_01.3.pdf.
  33. P. S. Sullivan, D. L. Hanson, S. Y. Chu, J. L. Jones, and J. W. Ward, “Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project,” Blood, vol. 91, no. 1, pp. 301–308, 1998. View at Google Scholar · View at Scopus
  34. O. Erhabor, O. A. Ejele, C. A. Nwauche, and F. I. Buseri, “Some haematological parameters in Human Immunodeficiency Virus (HIV) infected Africans: the Nigerian perspective,” Nigerian Journal of Medicine, vol. 14, no. 1, pp. 33–38, 2005. View at Google Scholar · View at Scopus
  35. R. Omoregie, E. U. Omokaro, O. Palmer et al., “Prevalence of anaemia among HIV-infected patients in Benin City, Nigeria,” Tanzania Journal of Health Research, vol. 11, no. 1, pp. 1–4, 2009. View at Google Scholar
  36. B. J. Ngowi, S. G. Mfinanga, J. N. Bruun, and O. Morkve, “Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania,” BMC Infectious Diseases, vol. 9, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. R. D. Semba and G. E. Gray, “Pathogenesis of anemia during human immunodeficiency virus infection,” Journal of Investigative Medicine, vol. 49, no. 3, pp. 225–239, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Savarino, G. P. Pescarmona, and J. R. Boelaert, “Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences?” Cell Biochemistry and Function, vol. 17, no. 4, pp. 279–287, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Ledru, S. Diagbouga, N. Meda et al., “A proposal for basic management of HIV disease in West Africa: use of clinical staging and haemogram data,” International Journal of STD and AIDS, vol. 9, no. 8, pp. 463–470, 1998. View at Publisher · View at Google Scholar · View at Scopus